THYROID DYSFUNCTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE: THE STATE OF THE PROBLEM AND THE WAYS OF SOLVING
https://doi.org/10.24884/1561-6274-2018-22-4-40-49
Abstract
Disturbance of the thyroid function is often detected in patients with different profiles. A special feature of patients with chronic kidney disease is the higher incidence of various thyroid function disturbances, especially hypothyroidism. It is known that in patients with chronic kidney disease (CKD) iodine excretion from the body is violated, since normally 90% of iodine is excreted in urine. Accumulation of high concentrations of inorganic iodine leads to the formation of the Wolf-Chaikoff effect: suppression of iodine organization in the thyroid gland and disruption of the thyroid hormones synthesis. Peripheral metabolism of thyroid hormones is also disturbed, namely, deiodinase type I activity is suppressed and peripheral conversion of T4 into T3 is inhibited (so-called low T3 syndrome). Therefore, patients with CKD are often diagnosed with hypothyroidism, and the origin of hypothyroidism is not always associated with the outcome of autoimmune thyroiditis. The article presents an overview of a large number of population studies of thyroid gland dysfunction in patients with CKD, as well as experimental data specifying the pathogenetic mechanisms of thyroid dysfunction in patients with CKD. Therapeutic tactics are still not regulated. However, in a number of studies, replacement therapy with thyroid hormones in patients with CKD had some advantages.
About the Authors
A. R. Volkova
First Pavlov St. Petersburg State Medical University
Russian Federation
Russian Federation
197022, Russia, St-Petersburg, L. Tolstoy st., 6–8, build. 11
Department of the Faculty therapy
Prof. Anna R. Volkova MD, PhD, DMedSci Phone +79213342963
O. D. Dygun
First Pavlov St. Petersburg State Medical University
Russian Federation
Russian Federation
197022, Russia, St-Petersburg, L. Tolstoy st., 6–8, build. 11
Department of the Faculty therapy
Olga D. Dygun MD Phone +79657971179
B. G. Lukichev
First Pavlov St. Petersburg State Medical University
Russian Federation
Russian Federation
197022, Russia, St-Petersburg, L. Tolstoy st., 17, build. 54
MD, PhD, DMedSci Phone +7 921-572-31-50
Prof. Boris G. Lukichev MD, PhD, DMedSci Phone +7 921-572-31-50
S. V. Dora
First Pavlov St. Petersburg State Medical University
Russian Federation
Russian Federation
197022, Russia, St-Petersburg, L. Tolstoy st., 6–8, build. 11
Department of the Faculty therapy
Ass. Svetlana V. Dora MD, PhD Phone +79213194973
O. V. Galkina
Research Institute First Pavlov St. Petersburg State Medical University
Russian Federation
Russian Federation
197022, Russia, St-Petersburg, L. Tolstoy st., 17, build. 54
Laboratory of biochemical homeostasis of the Nephrology Scientific
Head Olga V. Galkina, MD, PhD. Phone +7 921-385-52-86
References
1. Duntas LH, Biondi B. New insights into subclinical hypothyroidism and cardiovascular risk. Semin Thromb Hemost 2011; 37:27–34. doi:10.1055/s-0030-1270068
2. Смирнов АВ, Шилов ЕМ, Добронравов ВА и др. Национальные рекомендации. Хроническая болезнь почек: основные принципы скрининга, диагностики, профилактики и подходы к лечению. Клиническая нефрология 2012:4–26. [Smirnov AV, Shilov EM, Dobronravov VA i dr. National recommendations. Chronic kidney disease: the basic principles of screening, diagnosis, prevention and treatment approaches. Clinicheskaia nefrologiia 2012:4–26]
3. Фадеев ВВ. По материалам клинических рекомендаций Американской ассоциации клинических эндокринологов и Американской тиреоидной ассоциации по диагностике и лечению гипотиреоза у взрослых. Клиническая и экспериментальная тиреоидология 2012;8:9–16. doi:10.4158/EP12280. GL [Fadeev VV. Based on the clinical recommendations of the American Association of Clinical Endocrinologists and the American Thyroid Association for Diagnosis and Treatment of Hypothyroidism in Adults. Clinicheskaia i e`ksperimental`naia tireoidologiia 2012;8:9–16. doi:10.4158/EP12280.GL]
4. Сазонова ЕГ, Мохорт ТВ. Тиреоидная функция при сахарном диабете, осложненном хронической болезнью почек. Международный эндокринологический журнал 2013;50:62–67. [Sazonova EG, Mohort TV. Thyroid function in diabetes mellitus complicated by chronic kidney disease. Mezhdunarodny`i` e`ndokrinologicheskii` zhurnal 2013;50:62–67]
5. Орлова ММ, Родионова ТИ. Состояние функции почек у пациентов с гипотиреозом (обзор). Медицинский альманах 2013:112–114. [Orlova MM, Rodionova TI. Kidney function in patients with hypothyroidism (review). Meditcinskii` al`manakh 2013:112-114]
6. Schultheiss UT, Daya N, Grams ME et al. Thyroid function, reduced kidney function and incident chronic kidney disease in a community-based population: the Atherosclerosis Risk in Communities study. Nephrol Dial Transplant 2017;32:1874–1881. doi:10.1093/ndt/gfw301
7. Åsvold BO, Bjøro T, Vatten LJ. Association of thyroid function with estimated glomerular filtration rate in a population-based study: The HUNT study. Eur J Endocrinol 2011;164:101– 105. doi:10.1530/EJE-10-0705
8. Inoue K, Tsujimoto T, Saito J et al. Association Between Serum Thyrotropin Levels and Mortality Among Euthyroid Adults in the United States. Thyroid 2016;26:thy.2016.0156. doi:10.1089/thy.2016.0156
9. Meuwese CL, Gussekloo J, de Craen AJ et al. Thyroid status and renal function in older persons in the general population. J Clin Endocrinol Metab 2014;99:2689–2696. doi:10.1210/jc.2013-3778
10. Lo JC, Chertow GM, Go AS et al. Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. Kidney Int 2005;67:1047–1052. doi:10.1111/j.1523-1755.2005.00169.x
11. Chonchol M, Lippi G, Salvagno G et al. Prevalence of subclinical hypothyroidism in patients with chronic kidney disease. Clin J Am Soc Nephrol 2008;3:1296–1300. doi:10.2215/CJN.00800208
12. Chandra A. Prevalence of hypothyroidism in patients with chronic kidney disease: a cross-sectional study from North India. Kidney Res Clin Pract 2016;35:165–168. doi:10.1016/j.krcp.2016.06.003
13. Chaker L, Sedaghat S, Hoorn EJ et al. The association of thyroid function and the risk of kidney function decline: a population- based cohort study. Eur J Endocrinol 2016;175:653– 660. doi:10.1530/EJE-16-0537
14. Rhee CM, Ravel VA, Streja E et al. Thyroid Functional Disease and Mortality in a National Peritoneal Dialysis Cohort. J Clin Endocrinol Metab 2016;101:4054–4061. doi:10.1210/jc.2016-1691
15. Rhee CM, Kalantar-Zadeh K, Streja E et al. The relationship between thyroid function and estimated glomerular filtration rate in patients with chronic kidney disease. Nephrol Dial Transplant 2015;30:282–287. doi:10.1093/ndt/gfu303
16. Chuang M-H, Liao K-M, Hung Y-M et al. Abnormal Thyroid-Stimulating Hormone and Chronic Kidney Disease in Elderly Adults in Taipei City. J Am Geriatr Soc 2016;64:1267–1273. doi:10.1111/jgs.14102
17. Chuang M-H, Liao K-M, Hung Y-M et al. Association of TSH Elevation with All-Cause Mortality in Elderly Patients with Chronic Kidney Disease. PLoS One 2017;12:e0168611. doi:10.1371/journal.pone.0168611
18. Lee DY, Jee JH, Jun JE et al. The effect of TSH change per year on the risk of incident chronic kidney disease in euthyroid subjects. Endocrine 2017;55:503–512. doi:10.1007/s12020-016-1138-8
19. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med 2001; 344:501–509. doi:10.1056/NEJM200102153440707
20. Klein I, Danzi S. Thyroid Disease and the Heart. Curr Probl Cardiol 2016;41:65–92. doi:10.1016/j.cpcardiol.2015.04.002
21. Cini G, Carpi A, Mechanick J et al. Thyroid hormones and the cardiovascular system: pathophysiology and interventions. Biomed Pharmacother 2009;63:742–753. doi:10.1016/j.biopha.2009.08.003
22. Klein I, Danzi S. Thyroid disease and the heart. Circulation 2007;116:1725–1735. doi:10.1161/CIRCULATIONAHA.106.678326
23. Koch CA, Chrousos GP. Overview of Endocrine Hypertension. In: De Groot LJ, Chrousos G, Dungan K et al. Endotext. South Dartmouth (MA): 2000
24. Danzi S, Klein I. Thyroid hormone and blood pressure regulation. Curr Hypertens Rep 2003;5:513–520
25. Kotsis V, Alevizaki M, Stabouli S et al. Hypertension and hypothyroidism: results from an ambulatory blood pressure monitoring study. J Hypertens 2007;25:993–999. doi:10.1097/HJH.0b013e328082e2ff
26. Stabouli S, Papakatsika S, Kotsis V. Hypothyroidism and hypertension. Expert Rev Cardiovasc Ther 2010;8:1559–1565. doi:10.1586/erc.10.141
27. Vargas F, Moreno JM, Rodriguez-Gomez I et al. Vascular and renal function in experimental thyroid disorders. Eur J Endocrinol 2006;154:197–212. doi:10.1530/eje.1.02093
28. Ichihara A, Kobori H, Miyashita Y et al. Differential effects of thyroid hormone on renin secretion, content, and mRNA in juxtaglomerular cells. Am J Physiol 1998;274: E224-31
29. Vargas F, Rodriguez-Gomez I, Vargas-Tendero P et al. The renin-angiotensin system in thyroid disorders and its role in cardiovascular and renal manifestations. J Endocrinol 2012; 213: 25–36. doi:10.1530/JOE-11-0349
30. van Hoek I, Daminet S. Interactions between thyroid and kidney function in pathological conditions of these organ systems: a review. Gen Comp Endocrinol 2009; 160:205–215. doi:10.1016/j.ygcen.2008.12.008
31. Barlet C, Doucet A. Lack of stimulation of kidney Na-KATPase by thyroid hormones in long-term thyroidectomized rabbits. Pflugers Arch 1986;407:428–431
32. Zimmerman RS, Ryan J, Edwards BS et al. Cardiorenal endocrine dynamics during volume expansion in hypothyroid dogs. Am J Physiol 1988;255:R61-6. doi:10.1152/ajpregu.1988.255.1.R61
33. Singer MA. Of mice and men and elephants: metabolic rate sets glomerular filtration rate. Am J Kidney Dis 2001;37:164–178
34. Schmid C, Brandle M, Zwimpfer C et al. Effect of thyroxine replacement on creatinine, insulin-like growth factor 1, acidlabile subunit, and vascular endothelial growth factor. Clin Chem 2004;50:228–231. doi:10.1373/clinchem.2003.021022
35. Sato Y, Nakamura R, Satoh M et al. Thyroid hormone targets matrix Gla protein gene associated with vascular smooth muscle calcification. Circ Res 2005;97: 550–557. doi:10.1161/01.RES.0000181431.04290.bd
36. Suher M, Koc E, Ata N et al. Relation of thyroid disfunction, thyroid autoantibodies, and renal function. Ren Fail 2005;27:739–742
37. Michael UF, Barenberg RL, Chavez R et al. Renal handling of sodium and water in the hypothyroid rat. Clearance and micropuncture studies. J Clin Invest 1972;51:1405–1412. doi:10.1172/JCI106936
38. Hanna FW, Scanlon MF. Hyponatraemia, hypothyroidism, and role of arginine- vasopressin. Lancet (London, England) 1997;350:755–756. doi:10.1016/S0140-6736(05)62563-9
39. Montenegro J, Gonzalez O, Saracho R et al. Changes in renal function in primary hypothyroidism. Am J Kidney Dis 1996;27:195–198
40. Sato K, Okamura K, Yoshinari M et al. Reversible primary hypothyroidism and elevated serum iodine level in patients with renal dysfunction. Acta Endocrinol (Copenh) 1992;126:253–259
41. Gardner DF, Mars DR, Thomas RG et al. Iodine retention and thyroid dysfunction in patients on hemodialysis and continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1986;7:471–476
42. Кеттайл ВМ, Арки РА. Патофизиология эндокринной системы. BINOM Publishers 2001. 81. [Kettai`l VM, Arki RA. Patofiziologiia e`ndokrinnoi` sistemy`. BINOM Publishers 2001. 81.]
43. Beckers C, Machiels J, Soyez C et al. Metabolic clearance rate and production rate of thyroid-stimulating hormone in man. Horm Metab 1971; 3:34–36. doi:10.1055/s-0028- 1095044
44. Bartalena L, Pacchiarotti A, Palla R et al. Lack of nocturnal serum thyrotropin (TSH) surge in patients with chronic renal failure undergoing regular maintenance hemofiltration: a case of central hypothyroidism. Clin Nephrol 1990; 34:30–34
45. Medri G, Carella C, Padmanabhan V et al. Pituitary glycoprotein hormones in chronic renal failure: evidence for an uncontrolled alpha-subunit release. J Endocrinol Invest 1993; 16: 169–174. doi:10.1007/BF03344939
46. Kaptein EM, Feinstein EI, Nicoloff JT et al. Serum reverse triiodothyronine and thyroxine kinetics in patients with chronic renal failure. J Clin Endocrinol Metab 1983; 57: 181–189. doi:10.1210/jcem-57-1-181
47. Hershman JM, Krugman LG, Kopple JD et al. Thyroid function in patients undergoing maintenance hemodialysis: unexplained low serum thyroxine concentration. Metabolism 1978;27:755–759
48. Faber J, Heaf J, Kirkegaard C et al. Simultaneous turnover studies of thyroxine, 3,5,3’ and 3,3’,5’-triiodothyronine, 3,5-, 3,3’-, and 3’,5’- diiodothyronine, and 3’-monoiodothyronine in chronic renal failure. J Clin Endocrinol Metab 1983; 56: 211–217. doi:10.1210/jcem-56-2-211
49. Kaptein EM, Quion-Verde H, Chooljian CJ, et al. The thyroid in end-stage renal disease. Medicine (Baltimore) 1988; 67:187–197
50. Lim VS, Fang VS, Katz AI et al. Thyroid dysfunction in chronic renal failure. A study of the pituitary-thyroid axis and peripheral turnover kinetics of thyroxine and triiodothyronine. J Clin Invest 1977;60: 522–534. doi:10.1172/JCI108804
51. Wartofsky L, Burman KD. Alterations in thyroid function in patients with systemic illness: the ‘euthyroid sick syndrome’. Endocr Rev 1982;3:164–217. doi:10.1210/edrv-3-2-164
52. Kaptein EM. Thyroid hormone metabolism and thyroid diseases in chronic renal failure. Endocr Rev 1996;17:45–63. doi:10.1210/edrv-17-1-45
53. US Renal Data System 1994 annual data report, the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney diseases, Bethesda, MD. Am J kidney Dis 1994;24 (suppl.: S12–94).
54. Namba H, Yamashita S, Kimura H et al. Evidence of thyroid volume increase in normal subjects receiving excess iodide. J Clin Endocrinol Metab 1993; 76: 605–608. doi:10.1210/jcem.76.3.8445017
55. Konno N, Makita H, Yuri K et al. Association between dietary iodine intake and prevalence of subclinical hypothyroidism in the coastal regions of Japan. J Clin Endocrinol Metab 1994; 78: 393–397. doi:10.1210/jcem.78.2.8106628
56. Kantor AF, Hoover RN, Kinlen LJ et al. Cancer in patients receiving long-term dialysis treatment. Am J Epidemiol 1987; 126: 370–376
57. Penn I. The effect of immunosuppression on pre-existing cancers. Transplantation 1993; 55: 742–747
58. Schneider AB. Carcinoma of follicular epithelium. In: Werner and Ingbar’s The Thyroid: A Fundamental and Clinical Text. 1991. 1121–1129
59. Brunner FP, Landais P, Selwood NH. Malignancies after renal transplantation: the EDTA- ERA registry experience. European Dialysis and Transplantation Association-European Renal Association. Nephrol Dial Transplant 1995;10 Suppl 1:74–80
60. Shin DH, Lee MJ, Kim SJ et al. Preservation of renal function by thyroid hormone replacement therapy in chronic kidney disease patients with subclinical hypothyroidism. J Clin Endocrinol Metab 2012; 97: 2732–2740. doi:10.1210/jc.2012-1663
61. den Hollander JG, Wulkan RW, Mantel MJ et al. Correlation between severity of thyroid dysfunction and renal function. Clin Endocrinol (Oxf) 2005; 62: 423–427. doi:10.1111/j.1365-2265.2005.02236.x
62. Hataya Y, Igarashi S, Yamashita T et al. Thyroid hormone replacement therapy for primary hypothyroidism leads to significant improvement of renal function in chronic kidney disease patients. Clin Exp Nephrol 2013;17:525–531. doi:10.1007/s10157-012-0727-y
Review
For citations:
Volkova A.R., Dygun O.D., Lukichev B.G., Dora S.V., Galkina O.V. THYROID DYSFUNCTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE: THE STATE OF THE PROBLEM AND THE WAYS OF SOLVING. Nephrology (Saint-Petersburg). 2018;22(4):40-49. (In Russ.) https://doi.org/10.24884/1561-6274-2018-22-4-40-49
Views:
25265
Email this article 